Year: 2019
Resolution Number: 70
Action Taken: Approved
Status:
Author(s): Jayne E. Courts, MD
Sponsor: Lee Begrow, DO
On behalf of: Kent County Delegation
Committee: A (Medical Care Delivery)
Resolved Section(s):
RESOLVED: That MSMS work with third-party payers in the State of Michigan to urge the provision of insurance coverage of transdermal lidocaine patches for other indications in addition to post-herpetic neuralgia; and be it furtherRESOLVED: That the Michigan Delegation to the American Medical Association (AMA) ask our AMA to encourage the United States Food and Drug Administration to consider approving other indications in addition to post-herpetic neuralgia for transdermal lidocaine patches; and be it furtherRESOLVED: That the Michigan Delegation to the American Medical Association (AMA) ask our AMA to urge the Centers for Medicare and Medicaid Services and third-party payers to provide insurance coverage of lidocaine transdermal patches for other indications in addition to post-herpetic neuralgia.
RESOLVED: That MSMS work with third-party payers in the State of Michigan to urge the provision of insurance coverage of transdermal lidocaine patches for other indications in addition to post-herpetic neuralgia; and be it furtherRESOLVED: That the Michigan Delegation to the American Medical Association (AMA) ask our AMA to encourage the United States Food and Drug Administration to consider approving other indications in addition to post-herpetic neuralgia for transdermal lidocaine patches; and be it furtherRESOLVED: That the Michigan Delegation to the American Medical Association (AMA) ask our AMA to urge the Centers for Medicare and Medicaid Services and third-party payers to provide insurance coverage of lidocaine transdermal patches for other indications in addition to post-herpetic neuralgia.
Fiscal Note: $25,000.00 or more as this resolution directs MSMS to pursue payer advocacy.
Resolution: View PDF for Prescription Coverage of the Lidocaine Transdermal Patch
For More Information, Contact: